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INTRODUCTION
Susac syndrome (SS), also known as retinal-cerebral-cochlear di -
sea se, although rare, needs to be considered as a differential diagnosis 
when unexplained visual field or visual acuity loss is detected in a 
patient. The triad of clinical symptoms that may not all be present at 
initial stages include diffuse encephalopathy, branch retinal artery 
occlusion, and sensorineural hearing loss(1). 
The etiology and pathogenesis of SS are not clearly understood. 
Autoimmune processes leading to the damage and inflammation-re-
lated occlusion of the microvessels in the brain, retina, and inner ear 
may play a causal role(2). Electroencephalogram, audiometry, fluores-
cein angiography (FA), and magnetic resonance imaging (MRI) of the 
brain sensitively detects the lesions(3).
Retinal abnormalities may have different clinical features. When 
arteriolar abnormalities are observed close to the central vision, 
symptoms of visual loss are more evident and the diagnosis may be 
faster. However, most cases have peripheral arteriolar micro-occlusive 
events, resulting in late ophthalmologic evaluation(4).
Multifocal arteriolar wall hyperfluorescence and peripheral branch 
artery occlusion can occur in normal-appearing fundus. Gass plaques 
(GP), which are yellow-white deposits seen at the mid segments of 
the arteriole, are a helpful finding for the diagnosis(5). If an initial FA 
is normal, it should be repeated at intervals during the early course 
of definite or suspected SS. FA abnormalities serve as a valuable bio-
marker, and serial FA may be useful in monitoring the effect of the 
treatment(1). 
The natural history and outcomes of SS are not fully understood. 
The disease may be active for several months and the time to remis-
sion can be long(4). After remission it results in various cognitive and 
functional damages. However, serious loss of vision is not observed in 
the majority of the patients.
The objectives of this study were to report a case of SS, its clinical 
manifestations, and to discuss the variability in clinical findings as 
well as management.
RESULTS 
A 19-year-old female was referred by a neurologist because of 
visual field loss in the left eye that lasted for 10 days. Three months 
earlier, the patient was examined for neurological abnormalities 
associated with bilateral hearing loss and underwent audiometry, 
impedance testing, brain MRI, and laboratory evaluations. The au-
diometry showed severe sensorineural hearing loss in the right ear 
and moderate sensorineural hearing loss in the left ear. The brain MRI 
showed multiple small lesions in the white matter in both cerebral 
hemispheres and at the corpus callosum (Figure 1). The total com-
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RESUMO
Relatamos o caso de uma mulher de 19 anos apresentando perda auditiva neu­
rossensorial bilateral, anormalidades mentais e perda de campo visual no olho 
es querdo. A acuidade visual era 20/20 em OD e 20/25 em OE. Paciente foi sistemati­
camente investigada, audiometria mostrou perda auditiva neurossensorial nos dois 
ouvidos e ressonância magnética nuclear (RNM) cerebral mostrou múltiplas pequenas 
lesões na substância branca em ambos os hemisférios cerebrais e no corpo caloso. A 
fundoscopia mostrou disco óptico normal bilateral, e embainhamento das arteríolas 
na média periferia do olho direito. Edema de retina e exsudatos algodonosos foram 
vistos. Angiofluoresceinografia mostrou vasculopatia arterial obstrutiva periférica 
bilateral. A paciente foi diagnosticada com síndrome Susac e tratada com fumarato 
de quetiapina, flunitrazepam e prednisona resultando em estabilização do quadro. 
Este caso mostra que um alto índice de suspeita levando ao reconhecimento precoce 
e tratamento é importante para evitar o diagnóstico tardio.
Descritores: Síndrome de Susac; Oclusão da artéria retiniana; Perda auditiva; Cor po 
caloso; Angiofluoresceinografia; Humano; Femino; Adulto; Relatos de casos
ABSTRACT
We report a case of a 19-year-old woman presenting bilateral neurosensorial hea-
ring loss, mental abnormalities, and loss of visual field in the left eye. Visual acuity 
was 20/20 in OD and 20/25 in OS. Patient was examined systemically. Audiometry 
showed sensorineural hearing loss in both ears. The magnetic resonance imaging 
(MRI) of brain revealed multiple small lesions in the white matter in both cerebral 
hemispheres and at the corpus callosum. Fundoscopy showed bilateral normal optic 
disc and sheathing of the arterioles in the middle periphery of OD. Retinal edema 
and cotton-wool spots were observed. Fluorescein angiography showed bilateral 
peripheral occlusive arterial vasculopathy. The patient was diagnosed with Susac 
syndrome and treated with quetiapine fumarate, flunitrazepam, and prednisone, 
which resulted in stabile outcome. This case shows that a high index of suspicion 
leading to early recognition and treatment is important to avoid irreversible damage.
Keywords: Susac syndrome; Retinal artery occlusion; Hearing loss; Corpus callosum; 
Fluorescein angiography; Humans; Female; Adult; Case reports
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Figure 2. FA images of both eyes of patient 2 shows microarterial nonperfusion in the peripheral retina. A) Microarterial occlusion in 
the peripheral retina temporosuperiorly in the left eye. B) A similar image of the peripheral retina temporally in the left eye shows a 
clearer image of the nonperfused arterioles. C) Unusual leakage pattern of arterial wall hyperfluorescence in the temporal inferior area 
not located in the arterial occlusion area. D) FA of the right eye shows important nonperfusion of the arterioles in the temporosuperior 





Figure 1. Brain MRI showing multiple small lesions at the corpus callosum.
plement, complement 3 and 4, antinuclear factor, thyroid-stimulating 
hormone, and T4 thyroid level were normal. 
Ophthalmologic examination showed best corrected visual 
acuity (BCVA) of 20/20 in OD and 20/25 in OS. Fundoscopy showed 
bilateral normal optic disc and sheathing of the arterioles in the 
middle periphery of OD. Retinal edema was seen in the temporal 
inferior quadrant and at the mid-peripheral temporal superior region 
associated with cotton-wool spots and sheathing of the arterioles 
nasally in the left eye.
FA showed bilateral normal choroidal perfusion -arterial nonper-
fusion at the peripheral superior and nasal inferior areas in right eye 
(OD) and in late phase temporal and inferiorly in left eye (OS), suggesting 
bilateral peripheral occlusive arterial vasculopathy, which was more 
evident in the left eye. Unusual leakage pattern of arterial wall in the 
temporal inferior area, but not located in the arterial occlusion area 
was noted in the right eye (Figure 2). 
The clinical findings and the exclusion of other diseases resulted 
in the diagnosis of SS. Quetiapine fumarate (100 mg/day), flunitra-
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zepam (0.5 mg/day), and prednisone (40 mg/day) were prescribed. 
Photocoagulation was applied to the ischemic areas to prevent re-
tinal neovascularization. 
DISCUSSION
Susac syndrome has an unknown etiology and is associated with 
varying outcomes(2,4,6). If not suspected of having the syndrome, the 
diagnosis may be delayed. Once the diagnosis is made, close neuro-
logic, otorhinolaryngologic, and ophthalmologic follow-up exami-
nations are very important(3) since the damage could be irreversible.
A specific routine for the management of this disease has not 
been described and approaches can be didactically divided into 
two strategies, namely the management of complications and the 
prevention of recurrences. The complications must be evaluated 
and treated according to the preference of the ophthalmologist to 
reestablish function. ASA, anticoagulants, steroids, immunosuppressors, 
and immunoglobulins have been shown to be effective for the pre-
vention of recurrence(6-8).
We observed no neovascularization in the peripheral retina and 
a BCVA of 20/20 in the case. 
The current study was limited by the retrospective design, the 
di versity of the therapeutic approaches, and the difficulties in eva-
luating the efficacy of treatment. However, the results of our study, 
which analyzed the diversity in systemic manifestations from early 
symptoms are important due to the low disease prevalence. 
Susac syndrome is considered as a rare disease. A high index of 
sus picion, which could lead to early recognition and treatment is im-
portant to avoid late diagnosis and to minimize the risk for persistent 
impairment. Prospective studies analyzing the effectiveness of the 
proposed treatments are critical for the establishment of therapeutic 
approaches for each clinical finding.
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